Kiniksa Pharmaceuticals International reported revenue of $243.60M and net income of $25.43M for the quarter ended Jun 2026, up 55.4% year over year. This income statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||
| Revenue | 12.10M | 18.75M | 32.19M | 26.97M | 99.14M | 61.88M | 48.34M | 71.47M | 67.05M | 83.39M | 79.86M | 108.63M | 112.21M | 122.54M | 137.78M | 156.80M | 180.85M | 202.13M | 214.27M | 243.60M | |||||||||||||||||
| Cost of RevenueCost of Rev | 2.77M | 3.87M | 4.22M | 5.03M | 6.94M | 6.71M | 7.04M | 7.70M | 9.09M | 9.58M | 10.58M | 12.32M | 20.11M | 17.90M | 17.87M | 18.60M | 20.26M | 20.95M | 20.80M | 23.57M | |||||||||||||||||
| Gross Profit | 9.33M | 14.88M | 27.97M | 21.94M | 92.20M | 55.17M | 41.31M | 63.77M | 57.96M | 73.81M | 69.28M | 96.31M | 92.11M | 104.64M | 119.92M | 138.19M | 160.60M | 181.18M | 193.47M | 220.03M | |||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 19.24M | 27.43M | 20.82M | 13.80M | 16.48M | 14.39M | 15.17M | 23.77M | 17.11M | 20.05M | 26.33M | 24.02M | 26.06M | 35.22M | 19.32M | 18.75M | 24.17M | 34.61M | 27.48M | 40.90M | |||||||||||||||||
| Selling, General & AdministrativeSG&A | 20.76M | 22.74M | 22.22M | 23.84M | 24.68M | 27.21M | 29.05M | 29.18M | 34.47M | 36.74M | 38.68M | 42.40M | 46.40M | 40.53M | 43.53M | 46.86M | 49.10M | 56.77M | 61.15M | 63.87M | |||||||||||||||||
| Other Operating ExpensesOther Opex | 2.77M | 4.70M | 12.47M | 8.70M | 11.56M | 14.23M | 15.32M | 21.68M | 26.40M | 26.52M | 31.38M | 42.34M | 49.42M | 66.08M | 61.66M | 71.02M | 83.56M | 90.97M | 96.37M | 111.64M | |||||||||||||||||
| Operating ExpensesOpex | 42.76M | 54.88M | 55.51M | 46.34M | 52.72M | 55.84M | 59.54M | 74.63M | 77.97M | 83.31M | 96.40M | 108.75M | 121.87M | 141.84M | 124.51M | 136.64M | 156.83M | 182.36M | 185.00M | 216.41M | |||||||||||||||||
| Operating IncomeOp. Inc | -30.67M | -36.13M | -23.32M | -19.37M | 46.41M | 6.05M | -11.20M | -3.15M | -10.93M | 0.08M | -16.54M | -0.12M | -9.66M | -19.30M | 13.27M | 20.16M | 24.02M | 19.77M | 29.27M | 27.19M | |||||||||||||||||
| EBIT | -30.67M | -36.13M | -23.32M | -19.37M | 46.41M | 6.05M | -11.20M | -3.15M | -10.93M | 0.08M | -16.54M | -0.12M | -9.66M | -19.30M | 13.27M | 20.16M | 24.02M | 19.77M | 29.27M | 27.19M | |||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.07M | -0.05M | -0.04M | 0.01M | 0.02M | 0.11M | 0.01M | -0.04M | -0.01M | 0.01M | -0.06M | -0.08M | 0.09M | -0.12M | -0.00M | 0.11M | -0.10M | 0.13M | -0.64M | -0.71M | |||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.03M | 0.10M | 0.32M | 0.79M | 1.83M | 1.92M | 2.43M | 2.37M | 2.27M | 2.42M | 2.46M | 2.32M | 2.29M | 2.72M | 3.14M | 3.50M | 3.41M | 3.95M | |||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||
| EBT | -30.66M | -43.80M | -23.29M | -19.27M | 46.73M | 90.91M | -9.36M | -1.24M | -8.50M | -72.03M | -14.28M | 2.30M | -7.20M | -16.98M | 15.56M | 22.88M | 27.16M | 23.27M | 32.68M | 31.14M | |||||||||||||||||
| Tax ProvisionsTaxes | -0.12M | 0.28M | 1.93M | 0.72M | -177.36M | 2.38M | 2.91M | -16.21M | 5.36M | -22.79M | 3.43M | 6.21M | 5.49M | -8.09M | 7.03M | 5.04M | 8.72M | 9.07M | 10.09M | 5.71M | |||||||||||||||||
| Profit After TaxPAT | -30.62M | -36.35M | -25.21M | -19.98M | 224.11M | 4.57M | -12.27M | 14.97M | -13.87M | 25.28M | -17.70M | -3.91M | -12.69M | -9.01M | 8.54M | 17.94M | 18.43M | 14.33M | 22.59M | 25.43M | |||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -30.54M | -44.08M | -25.21M | -19.98M | 224.09M | 88.53M | -12.27M | 14.97M | -13.86M | -49.24M | -17.70M | -3.91M | -12.69M | -8.89M | 8.54M | 17.83M | 18.43M | 14.20M | 22.59M | 25.43M | |||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -30.54M | -44.08M | -25.21M | -19.98M | 224.09M | 88.53M | -12.27M | 14.97M | -13.86M | -49.24M | -17.70M | -3.91M | -12.69M | -8.89M | 8.54M | 17.83M | 18.43M | 14.20M | 22.59M | 25.43M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -30.54M | -44.08M | -25.21M | -19.98M | 224.09M | 88.53M | -12.27M | 14.97M | -13.86M | -49.24M | -17.70M | -3.91M | -12.69M | -8.89M | 8.54M | 17.83M | 18.43M | 14.20M | 22.59M | 25.43M | |||||||||||||||||
| Net Income towards Common StockholdersNet Income | -30.54M | -44.08M | -25.21M | -19.98M | 224.09M | 88.53M | -12.27M | 14.97M | -13.86M | -49.24M | -17.70M | -3.91M | -12.69M | -8.89M | 8.54M | 17.83M | 18.43M | 14.20M | 22.59M | 25.43M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.44 | -0.64 | -0.36 | -0.29 | 3.23 | 1.28 | -0.18 | 0.21 | -0.20 | -0.70 | -0.25 | -0.06 | -0.18 | -0.12 | 0.12 | 0.24 | 0.25 | 0.19 | 0.30 | 0.33 | |||||||||||||||||
| EPS (Diluted) | -0.44 | -0.64 | -0.36 | -0.29 | 3.18 | 1.26 | -0.18 | 0.21 | -0.20 | -0.68 | -0.25 | -0.06 | -0.18 | -0.12 | 0.11 | 0.23 | 0.23 | 0.18 | 0.27 | 0.30 | |||||||||||||||||
| Shares Outstanding | 68.66M | 68.58M | 69.14M | 69.29M | 69.45M | 69.38M | 69.75M | 69.92M | 70.19M | 70.06M | 70.63M | 71.00M | 71.73M | 71.42M | 72.65M | 73.44M | 74.71M | 74.20M | 76.52M | 77.58M | |||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 68.66M | 68.58M | 69.14M | 69.29M | 70.55M | 70.42M | 69.75M | 71.63M | 70.19M | 71.92M | 70.63M | 71.00M | 71.73M | 71.42M | 76.15M | 77.94M | 80.04M | 78.98M | 82.41M | 83.40M | |||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 137.78M | 138.16M | 138.55M | 138.90M | 139.06M | 139.45M | 139.73M | 140.33M | 140.68M | 141.08M | 137.36M | 142.33M | 144.36M | 145.29M | 145.77M | 148.14M | 151.59M | 152.83M | 153.63M | 156.00M | |||||||||||||||||
| EBITDA | -30.67M | -36.13M | -23.32M | -19.37M | 46.41M | 6.05M | -11.20M | -3.15M | -10.93M | 0.08M | -16.54M | -0.12M | -9.66M | -19.30M | 13.27M | 20.16M | 24.02M | 19.77M | 29.27M | 27.19M | |||||||||||||||||
| Tax Rate | 0.38% | -0.64% | -8.27% | -3.72% | -379.50% | 2.62% | -31.03% | 1,308.39% | -63.02% | 31.63% | -24.01% | 269.62% | -76.27% | 47.65% | 45.14% | 22.05% | 32.12% | 38.98% | 30.87% | 18.34% |